(RYTM) Rhythm Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Rhythm Pharmaceuticals | (RYTM) share price targets
Complete technical analysis of Rhythm Pharmaceuticals (RYTM) by charts plus indicators, forecast predictions and share price targets for Rhythm Pharmaceuticals (RYTM)
Rhythm Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-25 View latest technical analysis
10 day averaged volume of Rhythm Pharmaceuticals is 606110
Date | Daily Closing Price | Open | High | Low | Volume |
25 Mon Nov 2024 | 59.92 | 61.38 | 63.08 | 59.81 | 1.189 times |
22 Fri Nov 2024 | 59.94 | 59.27 | 60.25 | 59.00 | 0.499 times |
21 Thu Nov 2024 | 59.03 | 59.40 | 60.32 | 58.00 | 0.459 times |
20 Wed Nov 2024 | 59.36 | 59.98 | 60.79 | 58.05 | 0.641 times |
19 Tue Nov 2024 | 59.97 | 58.00 | 60.13 | 57.59 | 1.118 times |
18 Mon Nov 2024 | 58.50 | 57.00 | 58.64 | 55.37 | 1.406 times |
15 Fri Nov 2024 | 56.23 | 60.21 | 60.21 | 55.82 | 1.139 times |
14 Thu Nov 2024 | 59.77 | 59.74 | 60.96 | 59.33 | 0.833 times |
13 Wed Nov 2024 | 60.07 | 64.40 | 65.25 | 59.88 | 1.402 times |
12 Tue Nov 2024 | 64.06 | 64.63 | 66.10 | 63.85 | 0.658 times |
My analysis of stock is bullish for shortterm, and stock might move up till 63.6 or till 70.3. Use a stoploss of 58.07 and if this stock hits its stoploss, then it can fall down till 52.5
Share price targets for Rhythm Pharmaceuticals (RYTM)
Target Type | Value |
Downside Target | 40.46 |
Downside Target | 45.00 |
Downside Target | 46.80 |
Downside Target | 50.09 |
Downside Target | 52.74 |
Downside Target | 53.92 |
Downside Target | 55.37 |
Downside Target | 59.81 |
Upside Target | 60.79 |
Upside Target | 63.08 |
Upside Target | 67.61 |
Upside Target | 68.58 |
Intraday share price targets for Rhythm Pharmaceuticals (RYTM)
Target Type | Value |
Downside Intraday Target | 58.79 |
Downside Intraday Target | 57.67 |
Upside Intraday Target | 62.06 |
Upside Intraday Target | 64.21 |
Upside Intraday Target | 60.94 |
Weekly technical analysis of Rhythm Pharmaceuticals (RYTM)
Date | Weekly Closing Price | Open | High | Low | Volume |
25 Mon Nov 2024 | 59.92 | 61.38 | 63.08 | 59.81 | 0.288 times |
22 Fri Nov 2024 | 59.94 | 57.00 | 60.79 | 55.37 | 0.702 times |
15 Fri Nov 2024 | 56.23 | 68.00 | 68.58 | 55.82 | 0.549 times |
08 Fri Nov 2024 | 67.33 | 48.79 | 67.61 | 48.44 | 4.451 times |
01 Fri Nov 2024 | 49.01 | 49.21 | 50.09 | 47.61 | 0.851 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Rhythm Pharmaceuticals (RYTM)
Date | Monthly Closing Price | Open | High | Low | Volume |
25 Mon Nov 2024 | 59.92 | 47.88 | 68.58 | 47.88 | 1.904 times |
31 Thu Oct 2024 | 47.73 | 52.16 | 52.74 | 46.80 | 0.727 times |
30 Mon Sep 2024 | 52.39 | 46.76 | 55.64 | 45.00 | 1.185 times |
30 Fri Aug 2024 | 47.29 | 48.08 | 50.22 | 40.61 | 0.789 times |
Scroll below to view daily charts
Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Rhythm Pharmaceuticals (RYTM)
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Rhythm Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Rhythm Pharmaceuticals in short term but the sell signal is initial and weak.
Rhythm Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Rhythm Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Rhythm Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 59.48 and Rhythm Pharmaceuticals (RYTM) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Rhythm Pharmaceuticals (RYTM) stock. Volume based technical analysis of Rhythm Pharmaceuticals (RYTM) stock is negative.
Rhythm Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Rhythm Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Rhythm Pharmaceuticals in short term but the sell signal is initial and weak.
Rhythm Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Rhythm Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Rhythm Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 59.48 and Rhythm Pharmaceuticals (RYTM) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Rhythm Pharmaceuticals (RYTM) stock. Volume based technical analysis of Rhythm Pharmaceuticals (RYTM) stock is negative.
Rhythm Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.